Agenus Inc (AGEN)
6.79
+1.02
(+17.68%)
USD |
NASDAQ |
Apr 23, 12:39
Agenus Price: 6.79 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 22, 2024 | 5.40 | 5.85 | 4.91 | 5.77 | 831199.0 |
Apr 19, 2024 | 4.96 | 5.87 | 4.900 | 5.31 | 1.464M |
Apr 18, 2024 | 5.36 | 6.14 | 4.775 | 4.97 | 1.671M |
Apr 17, 2024 | 6.34 | 6.52 | 5.38 | 5.40 | 1.527M |
Apr 16, 2024 | 6.46 | 6.98 | 6.155 | 6.30 | 1.323M |
Apr 15, 2024 | 8.58 | 9.22 | 6.43 | 6.50 | 1.459M |
Apr 12, 2024 | 8.43 | 8.86 | 7.02 | 8.15 | 1.400M |
Apr 11, 2024 | 8.718 | 8.924 | 8.43 | 8.87 | 349022.0 |
Apr 10, 2024 | 9.40 | 9.598 | 8.802 | 8.922 | 301580.0 |
Apr 09, 2024 | 9.146 | 9.80 | 8.80 | 9.73 | 805236.0 |
Apr 08, 2024 | 9.216 | 9.35 | 8.20 | 9.31 | 1.321M |
Apr 05, 2024 | 10.20 | 10.37 | 9.30 | 10.07 | 608341.0 |
Apr 04, 2024 | 10.80 | 11.18 | 10.00 | 10.12 | 575998.0 |
Apr 03, 2024 | 10.40 | 11.18 | 10.20 | 10.60 | 535179.0 |
Apr 02, 2024 | 11.60 | 11.60 | 10.20 | 10.24 | 482301.0 |
Apr 01, 2024 | 11.80 | 11.83 | 11.22 | 11.75 | 343196.0 |
Mar 28, 2024 | 11.13 | 11.60 | 11.01 | 11.60 | 275659.0 |
Mar 27, 2024 | 10.80 | 11.25 | 10.70 | 11.13 | 184067.0 |
Mar 26, 2024 | 11.58 | 11.58 | 10.66 | 10.73 | 257987.0 |
Mar 25, 2024 | 10.90 | 11.20 | 10.64 | 11.17 | 268304.0 |
Mar 22, 2024 | 11.41 | 11.58 | 10.50 | 10.92 | 255937.0 |
Mar 21, 2024 | 11.03 | 11.59 | 10.85 | 11.24 | 278878.0 |
Mar 20, 2024 | 11.38 | 11.38 | 10.60 | 11.09 | 307843.0 |
Mar 19, 2024 | 10.68 | 11.32 | 10.60 | 11.25 | 443107.0 |
Mar 18, 2024 | 11.40 | 11.43 | 9.70 | 10.59 | 677332.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.97
Minimum
Apr 18 2024
130.05
Maximum
Aug 30 2021
55.21
Average
52.96
Median
May 06 2019
Price Benchmarks
Protalix BioTherapeutics Inc | 1.185 |
InfuSystems Holdings Inc | 8.015 |
PAVmed Inc | 1.88 |
Allogene Therapeutics Inc | 3.465 |
Pfizer Inc | 26.25 |
Price Related Metrics
PS Ratio | 0.7768 |
Earnings Yield | -206.2% |
Market Cap | 142.22M |